Table 3 Comparison of age between different groups of COVID-19 patients with and without hypertension and healthy participants (control),

From: Association of DHEAS levels with COVID19 severity, gender, age, comorbidities, and management strategies

 

Age (years)

N

Mean ± SD

Median

Q1

Q3

p.value1

p.value2

p.value3

p.value4

1

HTN Positive/ Patient

158

63 ± 13

62

54

73

    

2

HTN Negative / Patient

440

45 ± 15

44

34

54

< 0.001

   

3

HTN Negative / Control

64

46 ± 14

49

35

56

< 0.001

0.711

  

1

HTN Positive / Inpatient

120

65 ± 14

66

55

74

    

2

HTN Positive / Outpatient

38

60 ± 12

58

51

69

0.048

   

3

HTN Negative / Inpatient

226

50 ± 16

49

38

61

< 0.001

0.001

  

4

HTN Negative/ Outpatient

214

40 ± 12

38

31

49

< 0.001

< 0.001

< 0.001

 

5

HTN Negative / Control

64

46 ± 14

49

35

56

< 0.001

< 0.001

0.047

0.001

1

HTN Positive / patient

Female

88

64 ± 13

64

55

75

    

Male

70

63 ± 14

61

53

70

0.486

   

2

HTN Negative / patient

Female

167

43 ± 14

41

32

53

    

Male

273

47 ± 15

46

35

56

0.012

   

3

HTN Negative / control

Female

24

47 ± 14

49

36

57

    

Male

40

45 ± 15

47

34

55

0.584

   
  1. P-value 1 compares group1 with other groups and p-value 2 compares group 2 with other groups. P-value 3 compares group 3 with other groups. P-value 4 compares group 4 with group 5. P-value < = 0.05 is significant.